AbstractWhy are potentially harmful, non-biomedical chemical substances, such as battery acid, chlorine, herbicides, and insecticides, used in the treatment of cutaneous leishmaniasis (CL)? What drives people to use these products as medicine? This article is about perceptions of CL, and the quest for a cure, in Suriname, South America. It highlights the associative style of reasoning behind health seeking and discusses the use of harmful chemical substances as medicines. Cutaneous leishmaniasis, a parasitic disease, affects 1 to 1.5 million people globally. It has a spectrum of clinical manifestations, but the most prominent and disfiguring elements are extensive dermatological ulceration and scar formation from lesions. The data upon whic...
Health-related stigma and its dramatic consequences for those stigmatized have long been a crucial c...
Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) due to Leishmania (V.) braziliens...
- Leishmaniasis remains a serious neglected illness worldwide, posing significant challenges in its ...
Cutaneous leishmaniasis is a parasitic skin infection, viewed by biomedical professionals as one of ...
Introduction Cutaneous leishmaniasis is a zoonotic disease caused by species of the protozoal parasi...
Background: Leishmaniasis is a parasitic infectious disease transmitted by vectors that cause three ...
International audienceETHNOPHARMACOLOGICAL RELEVANCE: Cutaneous leishmaniasis is a neglected disease...
Background: Leishmaniasis is a disease caused by parasites of the Leishmania type. Cutaneous leishma...
Leishmaniasis is a dismissed vector-borne tropical contamination thought to be an ailment of poor pe...
Health-related stigma and its dramatic consequences for those stigmatized have long been a crucial c...
We reviewed the evidence on community-based interventions for the prevention and control of cutaneou...
Ethnopharmacological relevance: Cutaneous and mucocutaneous leishmaniasis are neglected tropical dis...
Leishmaniasis is endemic in 88 countries on five continents. There are 1-1.5 million cases of cutane...
Ethnopharmacological relevance: Cutaneous and mucocutaneous leishmaniasis are neglected tropical dis...
International audienceBackgroundCutaneous leishmaniasis (CL) is a disease that often affects exposed...
Health-related stigma and its dramatic consequences for those stigmatized have long been a crucial c...
Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) due to Leishmania (V.) braziliens...
- Leishmaniasis remains a serious neglected illness worldwide, posing significant challenges in its ...
Cutaneous leishmaniasis is a parasitic skin infection, viewed by biomedical professionals as one of ...
Introduction Cutaneous leishmaniasis is a zoonotic disease caused by species of the protozoal parasi...
Background: Leishmaniasis is a parasitic infectious disease transmitted by vectors that cause three ...
International audienceETHNOPHARMACOLOGICAL RELEVANCE: Cutaneous leishmaniasis is a neglected disease...
Background: Leishmaniasis is a disease caused by parasites of the Leishmania type. Cutaneous leishma...
Leishmaniasis is a dismissed vector-borne tropical contamination thought to be an ailment of poor pe...
Health-related stigma and its dramatic consequences for those stigmatized have long been a crucial c...
We reviewed the evidence on community-based interventions for the prevention and control of cutaneou...
Ethnopharmacological relevance: Cutaneous and mucocutaneous leishmaniasis are neglected tropical dis...
Leishmaniasis is endemic in 88 countries on five continents. There are 1-1.5 million cases of cutane...
Ethnopharmacological relevance: Cutaneous and mucocutaneous leishmaniasis are neglected tropical dis...
International audienceBackgroundCutaneous leishmaniasis (CL) is a disease that often affects exposed...
Health-related stigma and its dramatic consequences for those stigmatized have long been a crucial c...
Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) due to Leishmania (V.) braziliens...
- Leishmaniasis remains a serious neglected illness worldwide, posing significant challenges in its ...